Eventos

Más información:

Invitamos a profesores, investigadores y estudiantes a someter sus trabajos de investigación en las áreas de ciencias farmacéuticas, biomedicina y microbiología aplicada. La recepción de trabajos libres (orales o carteles) estará abierta del 20 de agosto al 20 de septiembre de 2026:

https://simposio-qfb.org/resumenes

MEDICINE INNOVATES

A Rationally Designed SLPI Variant Suppresses NETosis at Nanomolar Levels - Medicine InnovatesSignificance Reference Felipe de Jesus Gonzalez-Contreras, Roxana Guadalupe Gutierrez-Vidal, Xristo Zarate, A recombinant human SLPI variant suppresses the formation of neutrophil extracellular traps at low concentrations in vitro, Protein Expression and Purification, Volume 232, 2025, 106721,

RESEARCH OUTREACH

Combatting antimicrobial resistance using novel small fusion proteinsAntibiotic resistance is a public health burden. Novel small fusion proteins with antimicrobial properties could be the answer.

MEDICINE INNOVATES

Breaking the Chain of Resistance: LL-37_Renalexin, a New Antimicrobial Peptide Against Superbugs - Medicine Innovatesdesigned a novel hybrid AMP named LL-37_Renalexin, which demonstrated potent antibacterial properties against various clinically relevant pathogen

Page updated

Google Sites

Report abuse